The aim of the study was to compare nocturnal sweating in patients diagnosed with obstructive sleep apnoea, OSA (before and following treatment) and with the general population.
The part of the measurements were done simultaneous with the Nox T3 device and Embletta type 3 monitor and the results showed no significant differences in the OSA severity.
Below is the link to the article
http://www.ncbi.nlm.nih.gov/pubmed/23674447
Comments